Korro Bio (KRRO) Change in Receivables (2024 - 2026)
Korro Bio's (KRRO) quarterly Change in Receivables came in at -$969000.0 in Q1 2026, down 525.0% YoY from $228000.0 in Q1 2025, and down 750.34% on a QoQ basis from $149000.0 in Q4 2025.
Korro Bio (KRRO) Change in Receivables (2024 - 2026) Analysis & Trends
Korro Bio (KRRO) has 3 years of Change in Receivables data on file, last reported at -$969000.0 in Q1 2026.
- Quarterly Change in Receivables fell 525.0% year-over-year to -$969000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.9 million (down 200.0% YoY) and the FY2025 annual result came in at -$727000.0, down 142.87% from the prior year.
- Change in Receivables declined to -$969000.0 in Q1 2026, from $149000.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $1.7 million in Q4 2024 to a low of -$969000.0 in Q1 2026.
- A 3-year average of $0.0 and a median of -$60000.0 in 2025 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2025 — Change in Receivables slumped 91.21% — and 2026, when it slumped 525.0%.
- Tracing KRRO's Change in Receivables over 3 years: stood at $1.7 million in 2024, then tumbled by 91.21% to $149000.0 in 2025, then tumbled by 750.34% to -$969000.0 in 2026.
- The last three Change in Receivables figures came in at -$969000.0 (Q1 2026), $149000.0 (Q4 2025), and -$269000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -53.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 117.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 31.60 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 94.29 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 37.16 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Korro Bio | 231.77 Mn | 116.73 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -969,000.00 |
| Mar 31, 2026 | -969,000.00 |
| Dec 31, 2025 | 149,000.00 |
| Dec 31, 2025 | 149,000.00 |
| Sep 30, 2025 | -269,000.00 |
| Sep 30, 2025 | -269,000.00 |
| Jun 30, 2025 | -835,000.00 |
| Jun 30, 2025 | -835,000.00 |
| Mar 31, 2025 | 228,000.00 |
| Mar 31, 2025 | 228,000.00 |
| Dec 31, 2024 | 1.70 Mn |
| Dec 31, 2024 | 1.70 Mn |